Sawtooth Solutions, LLC Genmab A/S Transaction History
Sawtooth Solutions, LLC
- $3.64 Billion
- Q4 2023
A detailed history of Sawtooth Solutions, LLC transactions in Genmab A/S stock. As of the latest transaction made, Sawtooth Solutions, LLC holds 22,305 shares of GMAB stock, worth $462,382. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,305
Previous 23,974
6.96%
Holding current value
$462,382
Previous $845,000
15.98%
% of portfolio
0.02%
Previous 0.03%
Shares
12 transactions
Others Institutions Holding GMAB
# of Institutions
248Shares Held
66.2MCall Options Held
729KPut Options Held
398K-
Alliancebernstein L.P. New York, NY14.7MShares$305 Million0.11% of portfolio
-
Orbis Allan Gray LTD Hamilton, D05.71MShares$118 Million0.8% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$105 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.43MShares$91.8 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.88MShares$59.7 Million0.45% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $13.6B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...